Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early Toxicities After High Dose Rate Proton Therapy in Cancer Treatments.
Doyen J, Sunyach MP, Almairac F, Bourg V, Naghavi AO, Duhil de Bénazé G, Claren A, Padovani L, Benezery K, Noël G, Hannoun-Lévi JM, Guedea F, Giralt J, Vidal M, Baudin G, Opitz L, Claude L, Bondiau PY. Doyen J, et al. Among authors: bourg v. Front Oncol. 2021 Jan 14;10:613089. doi: 10.3389/fonc.2020.613089. eCollection 2020. Front Oncol. 2021. PMID: 33520724 Free PMC article.
Bevacizumab: Is the lower the better for glioblastoma patients in progression?
Sirven-Villaros L, Bourg V, Suissa L, Mondot L, Almairac F, Fontaine D, Paquis P, Burel-VandenBos F, Frenay M, Thomas P, Lebrun-Frenay C. Sirven-Villaros L, et al. Among authors: bourg v. Bull Cancer. 2018 Dec;105(12):1135-1146. doi: 10.1016/j.bulcan.2018.07.010. Epub 2018 Oct 6. Bull Cancer. 2018. PMID: 30301554
18F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions.
Humbert O, Bourg V, Mondot L, Gal J, Bondiau PY, Fontaine D, Saada-Bouzid E, Paquet M, Chardin D, Almairac F, Vandenbos F, Darcourt J. Humbert O, et al. Among authors: bourg v. Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):558-568. doi: 10.1007/s00259-018-4240-8. Epub 2019 Jan 5. Eur J Nucl Med Mol Imaging. 2019. PMID: 30612162 Clinical Trial.
Added value of [18F]FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre study.
Darcourt J, Chardin D, Bourg V, Gal J, Schiappa R, Blonski M, Koulibaly PM, Almairac F, Mondot L, Le Jeune F, Collombier L, Kas A, Taillandier L, Verger A. Darcourt J, et al. Among authors: bourg v. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2727-2735. doi: 10.1007/s00259-023-06225-0. Epub 2023 Apr 22. Eur J Nucl Med Mol Imaging. 2023. PMID: 37086272
Complementary and alternative medicine use in glioma patients in France.
Le Rhun E, Devos P, Bourg V, Darlix A, Lorgis V, Ahle G, Boone M, Taillandier L, Curtit E, Gras L, Lebrun Frenay C, Gramatzki D, Ramirez C, Simon N, Weller M. Le Rhun E, et al. Among authors: bourg v. J Neurooncol. 2019 Dec;145(3):487-499. doi: 10.1007/s11060-019-03315-8. Epub 2019 Oct 21. J Neurooncol. 2019. PMID: 31637628 Free article.
Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults.
Picart T, Barritault M, Poncet D, Berner LP, Izquierdo C, Tabouret E, Figarella-Branger D, Idbaïh A, Bielle F, Bourg V, Vandenbos FB, Moyal EC, Uro-Coste E, Guyotat J, Honnorat J, Gabut M, Meyronet D, Ducray F. Picart T, et al. Among authors: bourg v. Neurooncol Adv. 2021 Apr 19;3(1):vdab061. doi: 10.1093/noajnl/vdab061. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34056608 Free PMC article.
[Neoadjuvant chemotherapy for symptomatic non operable grade II fibrillary astrocytoma in adults].
Lebrun C, Fontaine D, Vandenbos F, Chanalet S, Bourg V, Frénay M, Alchaar H, Bleuse A, Bondiau PY, Brunetto JL, Chatel M, Courdi A, Darcourt J, Fauchon F, Guibert F, Grellier P, Lanteri-Minet M, Lonjon M, Michiels JF, Paquis P, Paquis V, Ramaioli A, Rasendrarijao D; Groupe de Neuro-Oncologie de Nice. Lebrun C, et al. Among authors: bourg v. Rev Neurol (Paris). 2004 May;160(5 Pt 1):533-7. doi: 10.1016/s0035-3787(04)70982-0. Rev Neurol (Paris). 2004. PMID: 15269670 French.
68 results